drugset / Trial / NCT00335218

Fat Distribution in Healthy Early Postmenopausal Women

NCT00335218

Phase 4 Completed 67 enrolled Bayer
RandomizedParallel-groupTriple-blindTreatment

Summary

The aim of this study is to explore the effects of hormone replacement therapy with EV/DNG on abdominal fat distribution measured by magnetic resonance imaging.

Timeline

Start
2002-07
Primary completion
Completion
2004-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Dienogest Small molecule 2 mg
Subject estradiol valerate Unknown 2 mg

Indications